Recruiting to Phase 1 in oncology is always hard, for multiple reasons. Currently there is a crowded market of immunotheray alternatives for patients to consider and maybe poor old radiotherapies get sidelined by the sexy new things that attract headilnes in the paper.
ASX: CU6 Outlook., page-22
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.65 |
Change
-0.050(0.57%) |
Mkt cap ! $2.734B | |||
| Open | High | Low | Value | Volume |
| $8.65 | $8.79 | $8.40 | $14.40M | 1.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59 | $8.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.65 | 21036 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |